Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Practice Point
  • Published:

What are the long-term effects of chemotherapy and hormonal therapy for early breast cancer?

Nature Clinical Practice Oncology volume 2, pages 440–441 (2005)Cite this article

boxed-textEarly Breast Cancer Trialists' Collaborative Group (EBCTCG) (2005) Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomized trials. Lancet 365: 1687–1717

Background

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Sørlie T (2004) Molecular portraits of breast cancer: tumour subtypes as distinct disease entities. Eur J Cancer 40: 2667–2675

    Article  Google Scholar 

  2. Albain K et al. (2004) Abstract #37 Proc San Antonio Breast Cancer Symposium [http://www.abstracts2view.com/sabcs/index.php]

    Google Scholar 

  3. Berry DA et al. (2004) Abstract #29 Proc San Antonio Breast Cancer Symposium [http://www.abstracts2view.com/sabcs/index.php]

    Google Scholar 

  4. Winer EP et al. (2005) American Society of Clinical Oncology technology assessment on the use of aromatase inhibitors as adjuvant therapy for postmenopausal women with hormone receptor-positive breast cancer: status report 2004. J Clin Oncol 23: 619–629

    Article  CAS  Google Scholar 

  5. Goldhirsch A et al. Meeting Highlights: International Expert Consensus on the Primary Therapy of Early Breast Cancer 2005. Ann Oncol, in press

  6. Piccart-Gebhart MJ (2005) ASCO Meeting: The HERA Trial. [http://www.asco.org/ac/1,1003,_12-002511-00_18-0034-00_19-005816,00.asp] (accessed 28 July 2005)

Download references

Acknowledgements

The synopsis was written by Petra Roberts, Associate Editor, Nature Clinical Practice.

Author information

Authors and Affiliations

  1. University of Bern, Switzerland

    Aron Goldhirsch

  2. Department of Medicine, European Institute of Oncology, Milan, Italy

    Aron Goldhirsch

  3. Professor of Pediatrics (Biostatistics) at Harvard Medical School, Dana-Farber Cancer Institute, Boston, MA, USA

    Richard D Gelber

  4. Chief Executive Officer of The Cancer Council Australia and a Clinical Professor at the University of Sydney,

    Alan S Coates

Authors
  1. Aron Goldhirsch
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Richard D Gelber
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Alan S Coates
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Aron Goldhirsch.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Goldhirsch, A., Gelber, R. & Coates, A. What are the long-term effects of chemotherapy and hormonal therapy for early breast cancer?. Nat Rev Clin Oncol 2, 440–441 (2005). https://doi.org/10.1038/ncponc0296

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncponc0296

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing